Partner Headlines - TEVA

  1. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD
  2. Deutsche Bank Offers Quick Thoughts On Teva Pharmaceutical's ...

    Benzinga
  3. Benzinga's Weekend M&A Chatter

    Benzinga
  4. Teva Pharmaceutical

    IBD
  5. Sterne Agee Analyst: Court Win To Boost Net At Teva Pharmaceutical

    Benzinga
  6. Jefferies Weighs In On Specialty Pharmaceuticals After Management ...

    Benzinga
  7. US Stock Futures Slip Ahead Of Home Price, Consumer Confidence ...

    Benzinga
  8. OncoGenex to Regain Rights to Custirsen from Teva

    Benzinga
  9. United Therapeutics: Will It Pass Peers In 2015?

    IBD
  10. Teva Upgraded On Strength Of Copaxone MS Drug

    IBD
  11. UPDATE: Sterne Agee Upgrades Teva Pharmaceutical

    Benzinga
  12. Teva Pharmaceutical Releases 2015 Guidance, Sees Increased Generic ...

    Benzinga
  13. Merck-Cubist Deal Going Ahead Despite Patent Setback

    IBD
  14. Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI

    GuruFocus
  15. Why Opko Health Is a Better Investment Than Apple

    GuruFocus
  16. Benzinga's M&A Chatter for Tuesday November 18, 2014

    Benzinga
  17. Here Are The Top 25 Analysts On Wall Street

    Benzinga
  18. Insys Q3 Beats Estimates, Helping Stock Rebound

    IBD
  19. Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close ...

    Benzinga
  20. Teva ups full-year EPS outlook

    IBD
  21. UPDATE: Teva Posts Stronger-Than-Expected Q3 Profit, Lifts Forecast

    Benzinga
  22. Earnings Scheduled For October 30, 2014

    Benzinga
  23. Lannett Co. Gets Growth Rx In Generic Drugs Group

    IBD
  24. IPO Calendar: Biotech Companies Lead List Of 7 IPOs

    IBD
  25. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga
  26. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD
  27. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD
  28. Teva Reports Results of Strategic Review, Sees 14 Pipeline Projects ...

    Benzinga
  29. Fast Money Halftime Report Final Trade From October 2 - Twitter ...

    Benzinga
  30. Insys Therapeutics Up On Bullish Analyst Initiation

    IBD
  31. Teva Announces UK High Court Gives Positive Judgment In The Company's ...

    Benzinga
  32. 4 Biotechs That Might Be Bought Soon

    IBD
  33. Notable Hedge Funds Disclose Additions And Reductions To Holdings

    Benzinga
  34. Jana Partners LLC Files its 13F

    Benzinga
  35. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga
  36. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD
  37. Did George Soros Sell His Stake In Israeli Based SodaStream Due ...

    Benzinga
  38. 5 Drug Companies Profiting From Generics

    Benzinga
  39. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  40. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  41. George Soros Reveals His Largest Stake

    GuruFocus
  42. Sofinnova Ventures Closes $500M Fund

    FoxBusiness
  43. Israel's Market Appears Unfazed By Rising Conflict

    IBD
  44. George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps ...

    GuruFocus
  45. UPDATE: Teva Announces FDA Acceptance of NDA For Inhaler

    Benzinga
  46. 4 Top Performing Health Care Stocks With More Potential Upside

    Benzinga
  47. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  48. Top 4 Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  49. Diamond Hill Capital Comments on Teva Pharmaceutical Industries ...

    GuruFocus
  50. Diamond Hill Select Fund Commentary - First Quarter 2014

    GuruFocus
  51. Teva Pharmaceutical

    IBD
  52. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
  53. Teva Turmoil: Shares Up, Board Trimmed, CEO To Retire

    Benzinga
  54. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  55. Top Guru Held Asian Companies of the First Quarter

    GuruFocus
  56. Teva to buy Labrys Biologics

    IBD
  57. Chicago sues painkiller firms

    IBD
  58. Benzinga's M&A Chatter for Tuesday June 3, 2014

    Benzinga
  59. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  60. Richard Snow's Top Five Highlight Finance and Healthcare Sectors

    GuruFocus
  61. Benzinga's M&A Chatter for Wednesday May 7, 2014

    Benzinga
  62. ETF Outlook For Tuesday May 6, 2014 (EUFN, ITA, EIS, UAE)

    Benzinga
  63. Wrong Marketing Lesson by Big Pharma

    GuruFocus
  64. Sterne Agee Sees Mixed Factors For Teva Pharmaceutical Industries ...

    Benzinga
  65. Teva EPS tops; rivals seen?

    IBD
  66. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  67. Earnings Scheduled For May 1, 2014

    Benzinga
  68. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  69. Actavis Reporting Q1 Earnings Amid Merger Frenzy

    IBD
  70. US Stock Futures Up Ahead Of Earnings, Consumer Confidence Data

    Benzinga
  71. Morning Market Losers

    Benzinga
  72. Benzinga's Top #PreMarket Losers

    Benzinga
  73. UPDATE: Teva, Oncogenex Offer Top-Line Survival Results of Phase ...

    Benzinga
  74. Nasdaq Could Be in for a Bounce

    FoxBusiness
  75. Actavis got a Pfizer

    IBD
  76. Teva Settles Patent Litigation with Pfizer on Celebrex; Has Received ...

    Benzinga
  77. Sterne Agee Sees Teva Pharmaceutical Outperformance Continuing

    Benzinga
  78. Teva Unveils Generic Lunesta Tablets in US

    Benzinga
  79. Teva Announces First Approval and Launch of Generic Lovaza® Capsules ...

    Benzinga
  80. Market Wrap For April 7: Bears In Complete Control As Markets ...

    Benzinga
  81. Citigroup Slaps $70 Price Target on Teva, Highest on Street

    Benzinga
  82. Market Wrap For March 31: Stocks Rally As Yellen Confirms Support ...

    Benzinga
  83. Analyst Offers Insight on Favorable FDA Ruling for Teva Pharma

    Benzinga
  84. Market Wrap For March 28: Markets Still Positive Despite Giving ...

    Benzinga
  85. Teva Offers Most Attractive Risk-Reward Profile, Citigroup Says

    Benzinga
  86. UPDATE: Goldman Sachs Upgrades Teva Pharmaceutical Industries

    Benzinga
  87. Forest Laboratories' Recovery

    GuruFocus
  88. Should You Buy Actavis?

    GuruFocus
  89. Horizon Pharma Banks On Two-For-One Arthritis Drugs

    IBD
  90. UPDATE: JP Morgan Upgrades Teva Pharmaceuticals

    Benzinga
  91. UPDATE: Morgan Stanley Upgrades Teva Pharmaceutical Industries ...

    Benzinga
  92. Benzinga's Top Upgrades

    Benzinga
  93. US Stock Futures Edge Higher Ahead Of Consumer Sentiment Report

    Benzinga
  94. Pfizer Loses Patent On Celebrex, Plans To Appeal

    IBD
  95. Pfizer Loses Bid to Hold Celebrex Exclusivity to '15

    FoxBusiness
  96. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD
  97. UPDATE: Barclays Upgrades Teva Pharmaceutical Industries Limited ...

    Benzinga
  98. Teva upgraded on drug launch

    IBD
  99. Teva Upgraded On Strong Launch Of Next-Gen Copaxone

    IBD
  100. Weekly 52-Week Highs Highlight: COV, EQT, XLNX, TEVA

    GuruFocus
Trading Center